A bioluminescent reporter bioassay for in-process assessment of chimeric antigen receptor lentiviral vector potency
We have developed a simple bioassay for potency testing of CAR LV. The bioassay represents a significant improvement over other approaches to LV quantification because it reflects the MOA of the LV and selectively detects fully functional viral particles, making it ideal for inclusion in a matrix of in-process quality control assays for CAR LV.
Authors
- Jim Hartnett
- Julia Gilden (ORCID: https://orcid.org/0009-0002-7059-4935)
- Pete Stecha
- Mei Cong
Institutions
- Promega (United States) (US)
Publication Details
- Journal
- Antibody Therapeutics
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1093/abt/tbae032
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Promega